Seventeen division III varsity female athletes (7 Basketball, 5 Soccer, 3 Volleyball, 1 Softball, 1 Field Hockey) were recruited to participate in this investigation. All of the women were screened using a healthy history questionnaire and reported being in good health and free from injury. In addition, all of the women indicated that they had not taken any prescription or over the counter medications in the past 48 hours. Prior to data collection, each woman completed a document of informed consent and received a comprehensive verbal description of all the procedures along with an opportunity to ask questions. The research protocol and all associated documents were reviewed and approved by the Gettysburg College Institutional Review Board for the ethical treatment of human subjects. Data collection began with anthropometric measurements of height, weight and body composition. Height and weight were measured using a balance beam scale (Detecto, Webb City, MO) and were recorded in centimeters and kilograms respectively. Body composition was estimated using Lange skin-fold calipers (Beta Technology Corp., Cambridge, MD) and a three-site formula (triceps, thigh and supraillium) previously described by Jackson and Pollock (1985). To avoid the hormonal variations associated with the menstrual cycle, we only tested our subjects between the 5th and 14th day after the onset of their last menses. A heart rate monitor (Polar US, Lake Success, NY) with conduction gel was adjusted, fitted and then strapped around the subject. The seat post of the stationary cycle (Monark, Sweden) was then adjusted so that each woman had a 5 degree bend at the knee during the bottom phase of the pedal stroke. Once the woman was sitting comfortably on the cycle ergometer, she was then fitted with a neoprene face-mask that held the breath by breath neumotac apparatus which was connected to the metabolic cart (Medgraphics, St. Paul, MN). Sampling was reported in 30 sec intervals throughout the duration of the test and a time-down report of oxygen uptake and heart rate was printed after each test. A standard mercury sphygmomanometer was used to monitor blood pressure and a telemetry sensor from the metabolic cart was attached to the cycle to detect signals from the heart rate monitor. The subject was then prepped for a neuroselective electrodiagnostic sensory nerve evaluation using a Neurometer® (Neurotron, Baltimore, MD) to assess pain perception. This machine has been used widely since 1986 for the assessment of nociceptive nerve function in a variety of populations (Katims, 1998; Raj et al., 2001). The device delivers an atraumatic electrical stimulus to a set of gold-plated electrodes (Raj et al., 2001). The stimulus created is delivered directly to the nerve fiber bypassing the nerves end-organs and it is not influenced by skin thickness, subcutaneous fat or temperature (Katims, 1998). The reliability and validity of this machine has been described elsewhere (Katims, 1998). For this investigation, we chose the median nerve of the right index finger as the site for assessment. The index finger was chosen because it was away from the active tissue of the legs. In so doing, we have attempted to minimize the potential for simultaneous afferent impulses being received at the spinal cord, thus limiting the potential influence for gate-control differences. An example of the electrodiagnostic pain assessment site can be found in Figure 1. The protocol used in this study for inducing a quantifiable controlled pain stimulus incorporated a sinusoidal continuous electrical stimulus at 5 Hz which typically stimulates the small diameter unmyelinated nocioceptive ‘C’ fibers associated with ‘slow-pain’ (Katims, 1998). The stimulus increased in intensity every second by 10 mA until the woman could no longer tolerate the pain. Therefore, the duration of the pain stimulus was determined by the time it took to reach pain tolerance, which was typically less than 1 minute. Two separate pain perception variables were measured during each pain assessment. Pain Threshold (PT) was recorded when the tingling current first became painful. A verbal command of ‘Pain’ was used by the subject to indicate when PT was achieved. Pain Tolerance (PTOL) was recorded by the assessment device when the subject could no longer tolerate the painful current and the test was stopped. A verbal command of ‘Stop’ was used to tell the researcher to terminate the test. After the initial prepping procedures, a familiarization pain test was given to allow the subject to experience the unique electrical transcutaneous pain stimulus. This initial test also allowed the subject to become comfortable with the verbal commands associated with indicating each type of pain. Familiarization testing has been used extensively when inducing electrical transcutaneous pain (Katims, 1998). During the pain testing procedure the subjects rested their hands on the handle bars of the cycle ergometer. In between pain assessments the women were allowed to grasp the handlebars with both hands. A ten-minute rest period was given after the familiarization pain test. Data collection began after 10 minutes of quiet rest by obtaining baseline measures of PT, PTOL, relative oxygen consumption, heart rate and blood pressure. The metabolic cart collected data continuously until the end of the protocol. Once the baseline data was recorded, the subject was asked to warm-up by pedaling the cycle ergometer at 60 rpm’s at a resistance of 30 Watts for 4 minutes. After the fourth minute the resistance was increased by 30 Watts every minute until the subject reached 120 Watts. After a full minute of pedaling at this resistance, a second set of cardiovascular and pain assessments were obtained while the subject continued to pedal in order to examine changes in pain perception during exercise. A resistance of 120 Watts was chosen in an effort to provide a ‘moderately difficult’ cardiovascular challenge that has been previously demonstrated in active females (Lee and Nieman, 1990). After the assessment at 120 Watts, the resistance was increased again by 30 Watts every minute until the subject could no longer maintain 60 rpm’s or they verbally indicated volitional failure (VO2 peak). Ratings of Perceived Exertion (RPE) scores (1-10) (Pollock et al., 1998) were obtained every minute throughout the exercise protocol to help the investigators anticipate the achievement of VO2 peak. Immediately after the VO2 peak was achieved, another set of cardiovascular and pain measures were taken while the subject continued to pedal at 60 RPM’s with little resistance (30 Watts). After the final exercise assessments were recorded, the subject was asked to sit on the cycle without pedaling for a ten-minute recovery period, which concluded with a final set of cardiovascular and pain assessments. |